Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesEpsilon Healthcare Ltd

Epsilon Healthcare Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.024 AUD 0.00 ( 4.35%)
Last update at 2026-11-10T23:53:00Z
VOLUME
78393
Market Cap
7.78M

Momentum Score

…

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.02
Low
0.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Epsilon Healthcare Ltd operates residential aged-care facilities and related healthcare services in Australia and New Zealand, offering long-term care and support for older adults. Long-term growth drivers include demographic ageing, government funding for aged and community care, and potential scale benefits from operational consolidation; investors may find the company attractive for recurring revenue exposure to essential services and potential occupancy and efficiency improvements.

Key investment risks include changes to government funding or regulation, operational execution and staffing shortages that can affect care quality and occupancy, exposure to property valuation and market pricing, and any balance-sheet leverage that could limit flexibility.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
13.58M
Revenue Per Share
0.03
Gross Profit TTM
7.94M
Debt / Equity
4.74
ROE
50.27%
Net Debt
13.92M
ROCE
-16.73%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.02M -5.57M -3.31M -12.68M -10.37M
Net income -2.05M -3.25M -1.09M -12.68M -8.91M
Selling general administrative - 1.70M 2.87M 3.91M 6.85M
Selling and marketing expenses - 0.20M 0.21M 0.34M 0.42M
Gross profit 2.25M 4.17M 4.81M 1.34M 2.06M
Reconciled depreciation - 1.41M 1.48M 1.86M 1.56M
Ebit -2.22M -4.88M -2.79M -9.55M -7.05M
Ebitda -1.86M -2.13M -1.31M -7.69M -5.49M
Depreciation and amortization 0.36M 2.75M 1.48M 1.86M 1.56M
Operating income -2.22M -4.19M -2.42M -9.55M -7.05M
Other operating expenses 11.61M 7.73M 7.59M 16.80M 15.00M
Interest expense 1.26M 1.15M 0.52M 0.58M 0.80M
Tax provision - -0.13M -2.22M 0.00M -1.46M
Interest income - 1.14M 0.49M 0.60M 0.83M
Net interest income - -1.15M -0.52M -0.68M -0.80M
Income tax expense -0.97M 2.33M -2.22M 0.82M -1.46M
Total revenue 9.39M 5.60M 6.65M 7.11M 5.50M
Total operating expenses 4.47M 6.31M 5.75M 11.03M 11.56M
Cost of revenue 7.14M 1.43M 1.84M 5.78M 3.44M
Total other income expense net -0.80M -1.39M -0.89M -2.31M -0.07M
Net income from continuing ops - -5.49M -1.09M -12.68M -8.91M
Net income applicable to common shares - -5.49M -1.09M -13.29M -9.24M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 17.87M 10.46M 14.41M 20.50M 30.55M
Intangible assets - - - 0.00M 0.50M
Other current assets 0.30M 0.19M 0.03M 0.76M 0.71M
Total liab 14.88M 12.53M 6.87M 11.23M 10.98M
Total stockholder equity 2.99M -2.08M 7.54M 9.27M 19.57M
Other current liab 0.34M 0.23M 0.54M 0.74M 1.09M
Common stock 48.27M - - 46.88M 44.82M
Capital stock - 47.53M 46.81M 46.88M 44.82M
Retained earnings -51.66M -53.59M -48.10M -48.97M -35.97M
Other liab - - - 2.65M 3.19M
Good will - - - 0.00M 4.47M
Other assets - - - 0.12M 0.13M
Cash 0.24M 1.57M 0.34M 0.86M 2.34M
Total current liabilities 4.61M 11.50M 6.37M 7.93M 7.14M
Current deferred revenue 0.44M - - 0.64M 0.93M
Net debt 13.92M 6.29M 2.95M 2.34M 1.99M
Short term debt 0.58M - - 2.54M 3.67M
Short long term debt - 7.85M 3.29M 2.55M 3.55M
Short long term debt total 14.16M - - 3.20M 4.33M
Other stockholder equity - - - -0.61M -0.75M
Property plant equipment - - - 15.62M 17.48M
Total current assets 5.27M 3.69M 2.09M 4.76M 7.81M
Long term investments - - - - 0.13M
Net tangible assets - - - 9.88M 14.44M
Net receivables 3.52M 0.90M 1.13M 3.15M 2.16M
Inventory 1.20M 0.53M - 0.61M 2.42M
Accounts payable 3.26M 2.59M 1.20M 4.65M 2.38M
Accumulated other comprehensive income 6.38M - - 11.98M 11.47M
Non currrent assets other 0.44M 0.07M 0.07M 0.12M 0.13M
Non current assets total 12.60M 6.77M 12.32M 15.74M 22.74M
Capital lease obligations - 0.03M 0.16M 0.65M 0.78M
Long term debt total - - - 0.65M 0.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.10M -0.10M -0.53M -0.74M
Change to liabilities - - - 0.00M 0.31M
Total cashflows from investing activities 6.29M -0.10M -0.10M -0.53M -0.74M
Net borrowings - 4.13M 0.49M -1.28M -0.93M
Total cash from financing activities -4.48M 4.73M 0.34M 1.61M 1.47M
Net income -2.05M -3.25M -1.09M -12.68M -9.24M
Change in cash -1.32M 1.22M -0.47M -1.47M -4.63M
Begin period cash flow 1.57M 0.34M 0.81M 2.34M 6.97M
End period cash flow 0.24M 1.57M 0.34M 0.86M 2.34M
Total cash from operating activities -3.13M -3.41M -0.70M -2.57M -5.43M
Issuance of capital stock - 0.72M - - 2.45M
Depreciation 0.36M 2.75M 0.00M 1.86M 1.09M
Other cashflows from investing activities -0.24M 0.00M 0.00M 0.00M 0.01M
Change to inventory - - - - -0.46M
Change to account receivables - - 1.71M - -0.84M
Sale purchase of stock - 0.72M 0.00M 2.89M 2.51M
Other cashflows from financing activities -0.24M 4.13M -0.16M -0.53M -0.56M
Change to netincome - - - 8.24M 3.66M
Capital expenditures 0.17M 0.10M 0.10M 0.53M 0.75M
Change in working capital - 0.30M 0.00M 1.11M 1.04M
Stock based compensation - - 0.00M - -
Other non cash items -1.43M -2.91M 0.38M - -
Free cash flow -3.30M -3.50M -0.80M -0.53M -0.75M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EPN
Epsilon Healthcare Ltd		 0.00
4.35%		 0.02 - - 0.57 2.01 1.12 9.81
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Epsilon Healthcare Ltd

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

5 Goodyear Street, Southport, QLD, Australia, 4215

61 4 0810 8148

https://epsilonhealthcare.com.au

Name Title Year Born
Mr. Sonny Didugu Group COO & Joint Company Sec. NA
Ms. Laura Harvey Chief Operations Officer - Canada NA
Ms. Diandra Phipps Chief Operating Officer of Tetra Health NA
Mr. Mark Audet CFO & Joint Company Sec. NA
Mr. Jim Barlow Chief Agronomist and Regional Mang. of the Americas NA
Mr. Xiao Cui Executive Chairman NA
Mr. Daniel Sanghera Interim Chief Executive Officer NA
Ms. Li Lin Group Financial Controller NA
Mr. Marcelo Mora Company Secretary NA
Mr. Xiao Cui Executive Chairman NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…